+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


  • Book
  • June 2018
  • Elsevier Health Science
  • ID: 4455134

Concise and clinically focused, Gout, by Drs. Naomi Schlesinger and Peter E. Lipsky, provides a one-stop overview of recent developments regarding this common form of inflammatory arthritis. Impacting an estimated 8.3 million people in the U.S. alone, gout is seen frequently by both primary care physicians as well as rheumatologists. This resource provides detailed coverage of the epidemiology, causes, diagnosis, management, and treatment of patients with both acute and chronic gout.

  • Addresses key topics such as genetics, hyperuricemia, comorbidities of gout, treatment guidelines for acute and chronic gout, classification and diagnosis, and imaging.

  • Discusses future outlooks for improving pharmacological and nonpharmacological treatment options, including an overview of drugs in the pipeline.
  • Consolidates today's available information on this timely topic into one convenient resource.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Schlesinger: Gout

1. Uric Acid Biology and Purine Metabolism

2. Silent Monosodium Urate Crystals Deposits

3. Genetics of Hyperuricemia and Gout

4. Immunoinflammatory Nature of Gout

5. Tophus Biology

6. Synovial Fluid Analysis and Crystal Identification

7. Epidemiology of Gout and Hyperuricemia

8. Comorbidities

9. Imaging

10. Gout Classification and Diagnosis

11. Clinical Features of Gout

12. Quality of Life

13. Treatment Guidelines: the Good, the Bad, the Ugly

14. Nonpharmacological Treatments: Acute and Chronic Gout

15. Pharmacological Treatments: Acute Gout

16. Pharmacological Treatments: Chronic Gout

17. Treat to Target

18. Drugs in the Pipeline

Epilogue: Editors' Look into the Future


Naomi Schlesinger Professor of Medicine, Chief, Division of Rheumatology, Rutgers University Robert Wood Johnson Medical School, New Brunswick, New Jersey. Peter E Lipsky Co-founder and Chief Medical Officer, AMPEL BioSolutions LLC, Charlottesville, Virginia.